Level of major histocompatibility complex class i expression on endothelium in non-obese diabetic mice influences CD8 T cell adhesion and migration

Clinical and Experimental Immunology

Volumn 157, Issue 1, 2009, Pages 119-127

  Lozanoska Ochser, B ^a,b   Peakman, M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

CD8 T cells; Endothelial cells; Migration; NOD mouse; Trafficking

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INDUCIBLE COSTIMULATOR LIGAND; INTERCELLULAR ADHESION MOLECULE 1; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROGRAMMED DEATH LIGAND 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CELL ADHESION; CELL HETEROGENEITY; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; FEMALE; IMMUNOPHENOTYPING; LYMPHOCYTE MIGRATION; MICROVASCULATURE; MOUSE; MOUSE STRAIN; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; TISSUE SPECIFICITY;

ANIMALS; ANTIGENS, CD80; CD8-POSITIVE T-LYMPHOCYTES; CELL ADHESION; CELL MOVEMENT; DIABETES MELLITUS, TYPE 1; E-SELECTIN; ENDOTHELIAL CELLS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED NOD; MICE, TRANSGENIC; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL; SPECIES SPECIFICITY; THYMUS GLAND;

EID: 66849104438     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2009.03940.x     Document Type: Article

References (21)

1. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996 272 : 60 6.
2. Greening JE, Tree TI, Kotowicz KT et al. Processing and presentation of the islet autoantigen GAD by vascular endothelial cells promotes transmigration of autoreactive T-cells. Diabetes 2003 52 : 717 25.
3. Savinov AY, Wong FS, Stonebraker AC, Chervonsky AV. Presentation of antigen by endothelial cells and chemoattraction are required for homing of insulin-specific CD8+ T cells. J Exp Med 2003 197 : 643 56.
4. Pober JS. Immunobiology of human vascular endothelium. Immunol Res 1999 19 : 225 32.
5. Pober JS, Kluger MS, Schechner JS. Human endothelial cell presentation of antigen and the homing of memory/effector T cells to skin. Ann NY Acad Sci 2001 941 : 12 25. (Pubitemid 32928329)
6. Marelli-Berg FM, Jarmin SJ. Antigen presentation by the endothelium: a green light for antigen-specific T cell trafficking? Immunol Lett 2004 93 : 109 13.
7. Imagawa A, Hanafusa T, Tamura S et al. Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes: close correlation between serological markers and histological evidence of cellular autoimmunity. Diabetes 2001 50 : 1269 73.
8. Itoh N, Hanafusa T, Miyazaki A et al. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J Clin Invest 1993 92 : 2313 22.
9. Somoza N, Vargas F, Roura-Mir C et al. Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile. J Immunol 1994 153 : 1360 77.
10. Anderson MS, Bluestone JA. The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 2005 23 : 447 85.
11. Gearon CL, Hussain MJ, Vergani D, Peakman M. Lymphocyte vaccination protects prediabetic non-obese diabetic mice from developing diabetes mellitus. Diabetologia 1997 40 : 1388 95.
12. Smerdon RA, Peakman M, Hussain MJ, Vergani D. Lymphocyte vaccination prevents spontaneous diabetes in the non-obese diabetic mouse. Immunology 1993 80 : 498 501. (Pubitemid 23336703)
13. Xu XJ, Gearon C, Stevens E, Vergani D, Baum H, Peakman M. Spontaneous T-cell proliferation in the non-obese diabetic mouse to a peptide from the unique class II MHC molecule, I-Ag7, which is also protective against the development of autoimmune diabetes. Diabetologia 1999 42 : 560 5.
14. Lozanoska-Ochser B, Barone F, Pitzalis C, Peakman M. Atorvastatin fails to prevent the development of autoimmune diabetes despite inhibition of pathogenic beta-cell-specific CD8 T-cells. Diabetes 2006 55 : 1004 10.
15. Lieberman SM, Evans AM, Han B et al. Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes. Proc Natl Acad Sci USA 2003 100 : 8384 8.
16. Hakenberg J, Nussbaum AK, Schild H et al. MAPPP: MHC class I antigenic peptide processing prediction. Appl Bioinformatics 2003 2 : 155 8.
17. Loos T, Dekeyzer L, Struyf S et al. TLR ligands and cytokines induce CXCR3 ligands in endothelial cells: enhanced CXCL9 in autoimmune arthritis. Lab Invest 2006 86 : 902 16.
18. Middleton J, Patterson AM, Gardner L, Schmutz C, Ashton BA. Leukocyte extravasation: chemokine transport and presentation by the endothelium. Blood 2002 100 : 3853 60.
19. van den Elsen PJ, Holling TM, Kuipers HF, van der Stoep N. Transcriptional regulation of antigen presentation. Curr Opin Immunol 2004 16 : 67 75. (Pubitemid 38198119)
20. Kay TW, Campbell IL, Oxbrow L, Harrison LC. Overexpression of class I major histocompatibility complex accompanies insulitis in the non-obese diabetic mouse and is prevented by anti-interferon-gamma antibody. Diabetologia 1991 34 : 779 85.
21. Ono SJ, Issa-Chergui B, Colle E, Guttmann RD, Seemayer TA, Fuks A. IDDM in BB rats. Enhanced MHC class I heavy-chain gene expression in pancreatic islets. Diabetes 1988 37 : 1411 18.